News Archive Featured in the Media JeffNEWS

DATE: Saturday, March 27

TIME: 8 a.m. to 2:30 p.m.

LOCATION: Bluemle Life Sciences Building, Connelly Auditorium, Thomas Jefferson University, 233 S. 10th St., Philadelphia

EVENT: With the growing public interest in anti-aging therapies to extend longevity, many physicians are not equipped to comfortably advise patients about which therapies are sound medical practices and which constitute fraud.

The First Annual Jefferson Anti-Aging Symposium will attempt to address those issues by providing experts from around the country in human longevity and medical therapies to talk to physicians.

“The symposium will offer a fresh perspective on controversial treatments such as hormone modulation, caloric restriction, physical activity, wrinkle creams and dietary change, including supplementary use, with an emphasis on evidence-based medicine,” said symposium co-director Edmund Pribitkin, M.D., associate professor of otolaryngology-head and neck surgery, Jefferson Medical College of Thomas Jefferson University.

SPEAKERS:

• Alan Mintz M.D.
  Chief Medical Officer, Cenegenics, Inc., Las Vegas, Nev.
  Topic: Hormone Modulation Therapy
• George Roth, Ph.D
  Senior Guest Scientist, National Institute on Aging, Bethesda, Md.
  Topic: Caloric Restriction (CR) Strategies and the Promise of CR Mimetics
• Edmund Pribitkin, M.D.
  Thomas Jefferson University Hospital Topic: Primary Care Facial Rejuvenation--Botulinum Toxin (Botox) Injections, Fillers and Peelers
• Christine Arenson, M.D.
  Clinical Assistant Professor of Family Medicine and Director, Division of Geriatric Medicine, Jefferson
  Topic: Age Management Medicine and the Limits of Human Longevity

BACKGROUND: The symposium is sponsored by the Office of Continuing Medical Education, Jefferson Medical College, in conjunction with the Philadelphia Society of Facial Plastic Surgeons, Inc.